scispace - formally typeset
S

Si-Xue Cheng

Researcher at Wuhan University

Publications -  238
Citations -  12634

Si-Xue Cheng is an academic researcher from Wuhan University. The author has contributed to research in topics: Drug carrier & Micelle. The author has an hindex of 54, co-authored 236 publications receiving 10754 citations. Previous affiliations of Si-Xue Cheng include Sichuan University & University of South China.

Papers
More filters
Journal ArticleDOI

Fabrication of thermosensitive PCL‐PNIPAAm‐PCL triblock copolymeric micelles for drug delivery

TL;DR: A series of thermosensitive ABA type triblock poly(e-caprolactone)-b-poly(N-isopropylacrylamide)-poly(poly(e)-caprolactorone) (PCL-PNIPAAm-PCL) copolymers with different molecular weights were synthesized by the combination of ring opening polymerization and reversible addition-fragmentation chain transfer (RAFT) polymerization as mentioned in this paper.
Journal ArticleDOI

Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: properties and in vitro transfection studies.

TL;DR: The results indicated that the molecular weight of NMC-g-PEI has an important effect on cytotoxicity and transfection activity, and low molecular weight NMC -g- PEI has a good potential as efficient nonviral gene vectors.
Journal ArticleDOI

Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release.

TL;DR: Cytotoxicity study shows that the AC-PCL-HEMA/AAc copolymer exhibits good biocompatibility.
Journal ArticleDOI

Temperature‐Sensitive Poly(N‐isopropylacrylamide) Hydrogels with Macroporous Structure and Fast Response Rate

TL;DR: In this article, a macroporous temperature-sensitive poly(N-isopropylacrylamide) (PNIPA) hydrogels were prepared by a novel phase-separation technique to improve the response properties.
Journal ArticleDOI

A Tumor Targeted Chimeric Peptide for Synergistic Endosomal Escape and Therapy by Dual‐Stage Light Manipulation

TL;DR: Both in vitro and in vivo studies confirm the chimeric peptide‐based nanocarrier with a good synergistic effect is a promising nanoplatform for tumor treatments.